NCT07349381

A Food-Effect Study of CX11 in Healthy Participants

An Open-label, Randomized, Multiple-dose, Two-cycle, Two-way Crossover Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of CX11 Tablets in Healthy Participants

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (estimated)
• Sponsor: Vincentage Pharma Co., Ltd · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study is to evaluate the food effect (FE) on the PK of 200 mg CX11 in healthy participants

Conditions

• Obesity & Overweight
• Type 2 Diabetes

Interventions

Type	Name	Description
DRUG	CX11 (VCT220)	CX11 (VCT220) administered orally to participants who are in fasted/fed state in the first 6 consecutive days, and in fed/fasted state on the 7th day

Timeline

• Start date: 2026-03-04
• Primary completion: 2026-06-30
• Completion: 2026-09-30
• First posted: 2026-01-16
• Last updated: 2026-03-27

Locations

1 site across 1 country: China

Regulatory

• FDA-regulated drug study